Published in BMJ on January 22, 1994
A Different Approach to Preventing Thrombosis (ADAPT) | NCT02774265
Saphenous vein graft failure after coronary artery bypass surgery: insights from PREVENT IV. Circulation (2014) 3.04
Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin. Circulation (2012) 2.76
An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk. PLoS One (2011) 1.34
Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol (2008) 1.18
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review. CMAJ (2005) 1.18
Deep vein thrombosis: a clinical review. J Blood Med (2011) 1.15
Thromboprophylaxis after replacement arthroplasty. BMJ (2001) 1.10
Extracts from "clinical evidence": hip fracture. BMJ (2001) 1.08
Platelets are dominant contributors to hypercoagulability after injury. J Trauma Acute Care Surg (2013) 1.02
Randomised controlled trials in cardiovascular medicine: past achievements, future challenges. BMJ (1999) 1.00
Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med (2008) 0.95
Effect of inpatient quality of care on functional outcomes in patients with hip fracture. Med Care (2006) 0.93
Thromboprophylaxis in surgical patients. Can J Surg (2003) 0.91
Gathering intelligence on antiplatelet drugs: the view from 30 000 feet. When combined with other information overviews lead to conviction. BMJ (2002) 0.90
Does modern medicine increase life-expectancy: Quest for the Moon Rabbit? Indian Heart J (2016) 0.89
Pain management today - what have we learned? Clin Rheumatol (2006) 0.88
Thromboembolic prophylaxis in total joint arthroplasty. Thrombosis (2012) 0.87
Prevention of venous thromboembolism in hospitalized patients with cancer. J Clin Oncol (2009) 0.85
Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations. Indian J Anaesth (2010) 0.85
Cilostazol improves symptomatic intracranial artery stenosis - Evaluation of cerebral blood flow with single photon emission computed tomography. Surg Neurol Int (2011) 0.85
Aspirin resistance. Adv Hematol (2009) 0.83
Effect of prolonged unweighting of human skeletal muscle on neuromotor force control. Eur J Appl Physiol (2007) 0.83
Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism. Circ Res (2013) 0.81
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. Br J Clin Pharmacol (2014) 0.81
Addition of lenalidomide to melphalan in the treatment of newly diagnosed multiple myeloma: the National Cancer Institute of Canada Clinical Trials Group MY.11 trial. Curr Oncol (2007) 0.80
The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests. J Clin Epidemiol (2005) 0.80
Use of a haemostatic matrix (Floseal(®)) does not reduce blood loss in minimally invasive total knee arthroplasty performed under continued aspirin. Blood Transfus (2015) 0.80
Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery. Osteoporos Int (2010) 0.79
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Hip fracture. BMJ Clin Evid (2010) 0.79
Venous thromboembolic prophylaxis for hip fractures. Osteoporos Int (2010) 0.78
Effect of opium addiction on aspirin resistance in stable angina pectoris. Addict Health (2014) 0.78
Management and prevention of venous thromboembolism including surgery and the pregnant state. Ochsner J (2002) 0.76
Effect on deep venous thrombosis with flexion during total knee arthroplasty. HSS J (2006) 0.75
Localization of Short-Chain Polyphosphate Enhances its Ability to Clot Flowing Blood Plasma. Sci Rep (2017) 0.75
Do we still need dipyridamole? Br J Clin Pharmacol (1998) 0.75
Systemic inflammatory response syndrome and platelet count ≥250×10(9) are associated with venous thromboembolic disease. Int J Gen Med (2015) 0.75
A review of antiplatelet drugs, coronary artery diseases and cardiopulmonary bypass. J Extra Corpor Technol (2010) 0.75
Trials of antiplatelet therapy. BMJ (1994) 0.75
Comparison of 3,000 and 5,000 IU aXa/day certoparin in the prevention of deep-vein thrombosis after total hip replacement. Thromb J (2012) 0.75
Antiplatelet prophylaxis. Combination treatment may cause bleeding. BMJ (1994) 0.75
Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment. J Multidiscip Healthc (2014) 0.75
Antiplatelet prophylaxis. Consider the protective effect of blood loss from the gut. BMJ (1994) 0.75
Arterial indications for the low molecular weight heparins. Curr Control Trials Cardiovasc Med (2001) 0.75
Current developments in anti-platelet therapy. Wien Med Wochenschr (2006) 0.75
Safer non-cardiac surgery for patients with coronary artery disease. Preoperative aspirin does increase risk of perioperative bleeding. BMJ (1999) 0.75
Platelet function as a risk factor for venous thromboembolism in the Framingham Heart Study. Thromb Res (2017) 0.75
Deep vein thrombosis in a patient of adenomatous polyposis coli treated successfully with aspirin: A case report. Caspian J Intern Med (2016) 0.75
Clinical use of parnaparin in major and minor orthopedic surgery: a review. Vasc Health Risk Manag (2008) 0.75
Unresolved issues in the prevention of venous thromboembolism. Drugs (1996) 0.75
Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients. J Thromb Thrombolysis (2017) 0.75
Non-instrumented extradural lumbar spine surgery under low-dose acetylsalicylic acid: a comparative risk analysis study. Eur Spine J (2015) 0.75
Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst (1959) 94.48
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med (1988) 5.81
A 30-year survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg (1985) 2.61
Postoperative pulmonary embolism after hospital discharge. An underestimated risk. Arch Surg (1992) 2.33
Prevention of venous thromboembolism. Chest (1992) 1.81
Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med (1977) 1.65
Effect of dipyridamole on the incidence of clinically detectable deep-vein thrombosis. Lancet (1969) 1.62
Alpha 1-antitrypsin Pi-types in 965 COPD patients. Chest (1986) 1.61
Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J (1980) 1.37
Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat Med (1987) 1.28
Deep vein thrombosis in spinal cord injury: effect of prophylaxis with calf compression, aspirin, and dipyridamole. Paraplegia (1982) 1.24
Prevention of venous thromboembolism by administration of hydroxychloroquine. A preliminary report. J Bone Joint Surg Am (1976) 1.18
Deep venous thrombosis: a continuing problem. BMJ (1988) 1.13
Preventing venous thromboembolism in elderly patients with hip fractures: studies of low-dose heparin, dipyridamole, aspirin, and flurbiprofen. Br Med J (1977) 1.10
Controlled trial of platelet anti-aggregating agents and subcutaneous heparin in prevention of postoperative deep vein thrombosis in high risk patients. Haemostasis (1975) 1.06
Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily. J Bone Joint Surg Am (1985) 0.98
Prevention of postoperative deep vein thrombosis with dipyridamole and aspirin. Br Med J (1976) 0.96
Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine. Thromb Haemost (1986) 0.94
[Prevention of thromboembolism using acetylsalicylic acid in the surgery of hip-joint proximal fractures]. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed (1974) 0.94
Diagnosis, treatment, and prevention of pulmonary embolism. Report of the WHO/International Society and Federation of Cardiology Task Force. JAMA (1992) 0.94
Prevention of venous thromboembolism. Clin Haematol (1981) 0.92
Sex, aspirin, and venous thrombosis. Orthop Clin North Am (1978) 0.91
Prevention of postoperative deep venous thrombosis in legs by orally administered hydroxychloroquine sulphate. Br Med J (1974) 0.91
Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis. Thromb Diath Haemorrh (1973) 0.90
125I-fibrinogen leg scanning: reassessment of its role for the diagnosis of venous thrombosis in post-operative patients. Thromb Haemost (1993) 0.88
[Study of the platelet aggregation inhibitor MICRISTIN as to its efficacy in the prevention of thromboembolism in the postoperative phase following surgical interventions]. Folia Haematol Int Mag Klin Morphol Blutforsch (1979) 0.87
Trial of dipyridamole-aspirin in recurring venous thrombosis. Lancet (1981) 0.87
Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. Br J Clin Pharmacol (1990) 0.87
Prophylaxis of postoperative thromboembolism by low dose heparin and by acetylsalicylic acid given simultaneously. A double blind study. Thromb Res (1980) 0.86
[Prevention of postoperative thromboembolism with micristin in general surgical patients (author's transl)]. Zentralbl Chir (1979) 0.86
Prevention of postoperative thrombosis by aspirin. Am J Surg (1977) 0.85
Dipyridamole inhibits red cell-induced platelet activation. Atherosclerosis (1989) 0.85
Comparision of low dose heparin and low dose heparin combined with aspirin in prevention of deep vein thrombosis after total hip replacement. Pathol Biol (Paris) (1977) 0.85
[Prophylaxis of thromboembolism in abdominal surgery. Comparison of low dose heparin, acetylsalicylic acid and their combination (author's transl)]. MMW Munch Med Wochenschr (1980) 0.84
Aspirin-sulfinpyrazone in prophylaxis of deep venous thrombosis in total hip replacement. JAMA (1983) 0.84
Acetylsalicylic acid in combination with dihydroergotamine for preventing thromboembolism. Haemostasis (1982) 0.84
Hydroxychloroquine sulphate in prevention of deep venous thrombosis following fracture of the hip, pelvis, or thoracolumbar spine. J Bone Joint Surg Am (1976) 0.83
Dipyridamole-aspirin versus low doses of heparin in the prophylaxis of deep venous thrombosis in abdominal surgery. Thromb Res (1979) 0.83
The influence of aspirin on postoperative platelet kinetics and venous thrombosis. Surgery (1975) 0.83
Acetylsalicylic acid, low dose heparin, and a combination of both substances in the prevention of postoperative thromboembolism. A double blind study. Thromb Res (1977) 0.82
Prevention of postoperative deep vein thrombosis by a combination of subcutaneous heparin with subcutaneous dihydroergotamine or oral sulphinpyrazone. Thromb Haemost (1985) 0.81
Clinical and experimental evaluation of the thromboprophylactic effect of hydroxychloroquine sulfate after total hip replacement. Haemostasis (1981) 0.81
[Prevention of post-operative phlebothrombosis]. Medicina (B Aires) (1980) 0.81
An evaluation of suloctidil in the prevention of deep vein thrombosis in neurosurgical patients. Thromb Res (1985) 0.81
[Prevention of postoperative thrombo-embolism with acetylsalicyclic acid (author's transl)]. Dtsch Med Wochenschr (1974) 0.81
A meta-analysis of the studies of dihydroergotamine plus heparin in the prophylaxis of deep vein thrombosis. Chest (1986) 0.80
Failure of orally administered hydroxychloroquine sulphate to prevent venous thromboembolism following elective hip operations. J Bone Joint Surg Am (1977) 0.80
Investigation of the mechanism of false positive 125I-labelled fibrinogen scans. Br J Haematol (1974) 0.80